≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Use of etanautine orphenadrine

PheWeb

PDMED_ETANAUTINE_ORPHENADRINE

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N04AB

51

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

16

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

16

diagram downward connector

Include endpoints None

16

diagram downward connector
PDMED_ETANAUTINE_ORPHENADRINE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 16 7 9
Unadjusted prevalence (%) 0.00 0.00 0.01
Mean age at first event (years) 51.24 53.41 49.55

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: PDMED_ETANAUTINE_ORPHENADRINE – Use of etanautine orphenadrine
GWS hits:

Survival analyses between endpoints

↥

Plot

before Use of etanautine orphenadrine
after Use of etanautine orphenadrine

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of etanautine orphenadrine

↥